Market
BSE Prices delayed by 5 minutes... << Prices as on Feb 11, 2026 - 4:00PM >>  ABB India  5832.5 [ -0.60% ] ACC  1700.1 [ 0.32% ] Ambuja Cements  541 [ 0.51% ] Asian Paints  2393 [ -0.06% ] Axis Bank  1349.05 [ -0.54% ] Bajaj Auto  9856.7 [ 0.88% ] Bank of Baroda  291.2 [ 0.24% ] Bharti Airtel  2011.65 [ 0.04% ] Bharat Heavy  260.65 [ -5.58% ] Bharat Petroleum  388.45 [ 0.53% ] Britannia Industries  6016.4 [ 2.43% ] Cipla  1349.4 [ 0.54% ] Coal India  423.05 [ -1.86% ] Colgate Palm  2167.85 [ -0.79% ] Dabur India  520.75 [ 0.25% ] DLF  671 [ -0.11% ] Dr. Reddy's Lab.  1266.1 [ 0.83% ] GAIL (India)  163.5 [ -0.67% ] Grasim Industries  2925 [ -1.00% ] HCL Technologies  1551.2 [ -1.34% ] HDFC Bank  927.05 [ -0.54% ] Hero MotoCorp  5681.5 [ -1.20% ] Hindustan Unilever  2462.45 [ 0.34% ] Hindalco Industries  964.95 [ -0.38% ] ICICI Bank  1405.9 [ 0.03% ] Indian Hotels Co.  707.3 [ 0.71% ] IndusInd Bank  924.6 [ -0.33% ] Infosys  1472.4 [ -1.75% ] ITC  318.2 [ -0.98% ] Jindal Steel  1189 [ -0.19% ] Kotak Mahindra Bank  429.5 [ 0.03% ] L&T  4169.95 [ 0.01% ] Lupin  2212.7 [ 0.37% ] Mahi. & Mahi  3674.65 [ -0.02% ] Maruti Suzuki India  15412.75 [ 1.70% ] MTNL  32.66 [ -1.48% ] Nestle India  1302 [ -0.47% ] NIIT  79.19 [ -1.94% ] NMDC  85.69 [ 0.72% ] NTPC  368.45 [ 0.45% ] ONGC  274.6 [ 0.96% ] Punj. NationlBak  122.9 [ -0.04% ] Power Grid Corpn.  294.5 [ -0.02% ] Reliance Industries  1468.55 [ 0.69% ] SBI  1183 [ 3.40% ] Vedanta  700.55 [ 1.52% ] Shipping Corpn.  267.05 [ 0.02% ] Sun Pharmaceutical  1709.95 [ 0.14% ] Tata Chemicals  709.7 [ -0.89% ] Tata Consumer Produc  1150.4 [ -0.13% ] Tata Motors Passenge  384.65 [ 1.42% ] Tata Steel  207.65 [ -0.14% ] Tata Power Co.  375.3 [ 1.46% ] Tata Consult. Serv.  2909.4 [ -2.51% ] Tech Mahindra  1632.15 [ -0.73% ] UltraTech Cement  12945.1 [ -0.53% ] United Spirits  1412.1 [ 0.13% ] Wipro  229.75 [ -0.82% ] Zee Entertainment En  92.83 [ -0.90% ] 
Beta Drugs Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 1366.30 Cr. P/BV 6.18 Book Value (Rs.) 218.94
52 Week High/Low (Rs.) 2000/1354 FV/ML 10/1 P/E(X) 32.21
Bookclosure 26/03/2025 EPS (Rs.) 42.02 Div Yield (%) 0.00
Year End :2025-03 

We have audited the accompanying standalone Ind-AS financial statements of Beta Drugs Limited ('the
Company'), which comprise the Balance Sheet as at March 31, 2025, the Statement of Profit and Loss,
including the statement of Other Comprehensive Income, the Cash Flow Statement and the Statement of
Changes in Equity for the year then ended, and a summary of significant accounting policies and other
explanatory information.

Management's Responsibility for the Financial Statements

The Company's Board of Directors is responsible for the matters stated in Section 134(5) of the Companies
Act, 2013 ('the Act') with respect to the preparation of these standalone Ind-AS financial statements that
give a true and fair view of the financial position, financial performance including other comprehensive
income, cash flows and changes in equity of the Company in accordance with accounting principles
generally accepted in India, including the Indian Accounting Standards (Ind-AS) specified under Section
133 of the Act., read with the Companies (Indian Accounting Standards) Rules, 2015, as amended. This
responsibility also includes maintenance of adequate accounting records in accordance with the provisions
of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other
irregularities; selection and application of appropriate accounting policies; making judgments and estimates
that are reasonable and prudent; and the design, implementation and maintenance of adequate internal
financial control that were operating effectively for ensuring the accuracy and completeness of the
accounting records, relevant to the preparation and presentation of the Ind-AS financial statements that give
a true and fair view and are free from material misstatement, whether due to fraud or error.

Auditor's Responsibility

Our responsibility is to express an opinion on these standalone Ind-AS financial statements based on our
audit. We have taken into account the provisions of the Act, the accounting and auditing standards and
matters which are required to be included in the audit report under the provisions of the Act and the Rules
made there under. We conducted our audit of the standalone Ind-AS financial statements in accordance
with the Standards on Auditing, issued by the Institute of Chartered Accountants of India, as specified under
Section 143(10) of the Act. Those Standards require that we comply with ethical requirements and plan and
perform the audit to obtain reasonable assurance about whether the financial statements are free from
material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the
financial statements. The procedures selected depend on the auditor's judgment, including the assessment
of the risks of material misstatement of the standalone Ind-AS financial statements, whether due to fraud or
error. In making those risk assessments, the auditor considers internal financial control relevant to the
Company's preparation of the standalone Ind-AS financial statements that give a true and fair view in order
to design audit procedures that are appropriate in the circumstances. An audit also includes evaluating the
appropriateness of accounting policies used and the reasonableness of the accounting estimates made by
the Company's Directors, as well as evaluating the overall presentation of the standalone Ind-AS financial
statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a
basis for our audit opinion on the standalone Ind AS financial statements.

Opinion

In our opinion and to the best of our information and according to the explanations given to us, the
standalone Ind-AS financial statements give the information required by the Act in the manner so required
and give a true and fair view inconformity with the accounting principles generally accepted in India, of the
state of affairs of the Company as at March 31, 2025, its profit including other comprehensive income, its
cash flows and the changes in equity for the year ended on that date.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's report) Order, 2016 ('the Order') issued by the Central
Government of India in terms of subsection (11) of Section 143 of the Act, we give in the Annexure 1 a
statement on the matters specified in paragraphs 3 and 4 of the Order.

2. As required by Section 143 (3) of the Act, we report that:

a. We have sought and obtained all the information and explanations which to the best of our knowledge
and belief were necessary for the purpose of our audit;

b. In our opinion, proper books of account as required by law have been kept by the Company so far as it
appears from our examination of those books;

c. The Balance Sheet, Statement of Profit and Loss including the Statement of Other Comprehensive
Income, the Cash Flow Statement and Statement of Changes in Equity dealt with by this Report are in
agreement with the books of account;

d. In our opinion, the aforesaid standalone Ind-AS financial statements comply with the Indian Accounting
Standards specified under Section 133 of the Act, read with Companies (Indian Accounting Standards)
Rules, 2015, as amended;

e. On the basis of written representations received from the directors as on March 31, 2025, and taken on
record by the Board of Directors, none of the Director is disqualified as on March 31, 2025, from being
appointed as a director in terms of Section 164 (2) of the Act.

f. With respect to the adequacy of the internal financial controls over financial reporting of the Company and
the operating effectiveness of such controls, refers to our separate Report in “
Annexure B”;

g. With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the
Companies (Audit and Auditors) Rules, 2020, in our opinion and to the best of our information and according
to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its financial
statements.

ii. The Company did not have any long-term contracts including derivative contracts for which there were
any material foreseeable losses;

iii. There has been no amounts available which is required to be transferred, to the Investor Education and
Protection Fund by the Company;

iv. Based on our examination which included test checks, the company has used an accounting software for
maintaining its books of account which has a feature of recording audit trail (edit log) facility and the same
has operated throughout the year for all relevant transactions recorded in the software. Further, during the
course of our audit, we did not come across any instance of the audit trail feature being tampered with.

For KHURANA SHARMA & CO.

Place:- Chandigarh

Date: 15/05/2025 Chartered Accountants

UDIN:25568524BM KPNN9829

Sd/-

(CA VIBHOR KHURANA)

Partner
M. No- 568524
FRN: 010920N


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by